Strata Critical Medical (SRTA) Return on Invested Capital (2020 - 2025)
Strata Critical Medical (SRTA) has disclosed Return on Invested Capital for 6 consecutive years, with 0.09% as the latest value for Q4 2025.
- Quarterly Return on Invested Capital rose 7.0% to 0.09% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.09% through Dec 2025, up 7.0% year-over-year, with the annual reading at 0.26% for FY2023, 8.0% down from the prior year.
- Return on Invested Capital for Q4 2025 was 0.09% at Strata Critical Medical, up from 0.1% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.06% in Q3 2021, with the low at 0.27% in Q3 2024.
- Average Return on Invested Capital over 5 years is 0.17%, with a median of 0.15% recorded in 2022.
- The sharpest move saw Return on Invested Capital decreased -10bps in 2022, then increased 18bps in 2025.
- Over 5 years, Return on Invested Capital stood at 0.09% in 2021, then tumbled by -106bps to 0.19% in 2022, then tumbled by -43bps to 0.27% in 2023, then soared by 42bps to 0.15% in 2024, then soared by 43bps to 0.09% in 2025.
- According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.09%, 0.1%, and 0.12% for Q4 2025, Q3 2025, and Q2 2025 respectively.